- 2024 Policy Revision for Support of Type 1 Diabetes Mellitus Patients
-
Yoo JH
- KMID: 2556759
- J Korean Diabetes.
- 2024 Jun;25(2):89-92.
- doi: 10.4093/jkd.2024.25.2.89
Type 1 diabetes mellitus is a condition where the pancreas beta cells are destroyed due to autoimmune mechanisms or viral infections, resulting in the inability to produce insulin. The Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Do Type 1 and Type 2 Diabetes Have the Same Vascular Complications?
-
Cho YK
- KMID: 2556755
- J Korean Diabetes.
- 2024 Jun;25(2):62-68.
- doi: 10.4093/jkd.2024.25.2.62
Both type 1 and type 2 diabetes can lead to cardiovascular disease (CVD) and high mortality rates. The differing risks and vascular outcomes associated with these two types of diabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- Technological Innovations Transforming Diabetes Care in Practice
-
Kang S
- KMID: 2556754
- J Korean Diabetes.
- 2024 Jun;25(2):57-61.
- doi: 10.4093/jkd.2024.25.2.57
Diabetes care has experienced great changes due to technological advancements. Recent notable innovations in diabetes technology include real-time continuous glucose monitors, automated insulin delivery systems, insulin patches, and health management... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Face-to-Face Diabetes Nutrition Education
-
Lee J
- KMID: 2556760
- J Korean Diabetes.
- 2024 Jun;25(2):93-98.
- doi: 10.4093/jkd.2024.25.2.93
Non-face-to-face education has rapidly increased and become common due to the development of information and communication technology and mobile devices to help respond to COVID-19. Non-face-to-face education is conducted using... -
- CITED
-
- Close
- SHARE
-
- Close
- A Young Adult’s Life with Diabetes Based on a Social Ecological Model
-
Park YJ
- KMID: 2556761
- J Korean Diabetes.
- 2024 Jun;25(2):99-106.
- doi: 10.4093/jkd.2024.25.2.99
Young people with diabetes in Korea face a healthcare transition from adolescence to adulthood, involving various management tasks. Imagine a patient who is struggling to stay on track with their... -
- CITED
-
- Close
- SHARE
-
- Close
- 2023 Survey Results on the Perception of Diabetes Mellitus among the General Public
-
Yoo B, Lim SC, Koo MH, on Behalf of the Committee of Media-Public Relation of the Korean Diabetes Association
- KMID: 2556762
- J Korean Diabetes.
- 2024 Jun;25(2):107-116.
- doi: 10.4093/jkd.2024.25.2.107
Background: According to the Diabetes Fact Sheet published by the Korean Diabetes Association, as of 2020, one in six adults (16.7%) over the age of 30 were diagnosed with diabetes.... -
- CITED
-
- Close
- SHARE
-
- Close
- Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity
-
Min SH
- KMID: 2556758
- J Korean Diabetes.
- 2024 Jun;25(2):82-88.
- doi: 10.4093/jkd.2024.25.2.82
With an increasing prevalence of diabetes and its complications, there is a need for new therapies to improve glycemic control and weight management. Multireceptor agonists may be a means to... -
- CITED
-
- Close
- SHARE
-
- Close
- GLP-1/GIP Receptor Agonists: Mechanism of Action of Tirzepatide
-
Oh TJ
- KMID: 2556757
- J Korean Diabetes.
- 2024 Jun;25(2):76-81.
- doi: 10.4093/jkd.2024.25.2.76
Tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has demonstrated remarkable effectiveness in lowering glucose levels and reducing weight in the SURPASS and SURMOUNT... -
- CITED
-
- Close
- SHARE
-
- Close
- GLP-1 Receptor Agonist
-
Chung SM
- KMID: 2556756
- J Korean Diabetes.
- 2024 Jun;25(2):69-75.
- doi: 10.4093/jkd.2024.25.2.69
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by food intake from L cells of the ileum. GLP-1 contributes to blood glucose control through three main mechanisms: promoting glucose-dependent insulin... -
- CITED
-
- Close
- SHARE
-
- Close
